Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influence of Glitazones on HDL Vasodilation in Type 2 Diabetes
NCT00953498Phase 4Completed
- Sponsor
- Centre Hospitalier Universitaire Dijon Bourgogne
- Start
- Oct 2007
- Primary completion
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of pioglitazone, rosiglitazone in type 2 diabetes mellitus (T2DM), sponsored by Centre Hospitalier Universitaire Dijon Bourgogne. Started Oct 2007; status: completed.
02
Drugs
pioglitazonerosiglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00953498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00953498.